Rodman & Renshaw initiated coverage on Unity Biotechnology with a new price target

8/22/24 7:37:56 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Rodman & Renshaw initiated coverage of Unity Biotechnology with a rating of Buy and set a new price target of $8.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$UBX

Date	Price Target	Rating	Analyst
5/27/2025	$2.00	Buy → Neutral	H.C. Wainwright
5/16/2025	$6.00 → $1.00	Outperform → Neutral	Mizuho
8/22/2024	$8.00	Buy	Rodman & Renshaw
11/16/2023	$2.00 → $4.00	Neutral → Outperform	Wedbush
1/4/2022	$4.00	Neutral → Buy	Roth Capital
1/4/2022		Neutral → Buy	ROTH Capital
11/10/2021	$5.00 → $7.00	Neutral → Buy	Mizuho
6/28/2021		Sell → Buy	Citigroup